1. Human papillomavirus–associated cancers — United States, 2008–2012;Viens;MMWR,2016
2. Assessing the annual economic burden of preventing and treating anogenital human papillomavirus-related disease in the US: analytic framework and review of the literature;Insinga;Pharmacoeconomics,2005
3. FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP);Centers for Disease Control and Prevention (CDC);MMWR,2010
4. National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 Years — United States, 2015;Reagan-Steiner;MMWR,2016
5. Opportunities for improving cancer prevention at federally qualified health centers;Allen;J Cancer Educ,2013